More associated symptoms have been reported with the increasing number of COVID-19 cases worldwide. However, the precise impact of the disease on the urinary system and related urinary symptoms has yet to be adequately evaluated. The present study aims to investigate the subsequent lower urinary tract symptoms in patients attending Tadbir Clinic in Urmia City who have a history of infection due to COVID-19 within less than two months.
This study evaluated patients referred to the Urology Department of Tadbir Clinic in Urmia City between December 2020 and July 2021 who had tested positive for COVID-19 by RT-PCR within the past two months. The patient’s hospitalization history and the occurrence or exacerbation of urinary symptoms were recorded, and they completed the International Prostate Symptom Score (IPSS) questionnaire.
This study included 150 patients with a mean age of 44.12 years, including 80 males and 70 females. None of the patients had severe urinary symptoms. 92.7% of the patients had mild urinary symptoms, and 7.3% had moderate urinary symptoms. The prevalence of moderate urinary symptoms was significantly higher in females than in males (P-value = 0.04). Individuals with moderate urinary symptoms had a higher mean age than those with mild urinary symptoms (P-value = 0.03). Among patients with or without a history of hospitalization, including those with a history of intensive care unit (ICU) admission, there was no significant difference in the severity of urinary symptoms (P-value = 0.5). Nocturia was the most common symptom reported by patients after the COVID-19 infection.
The severity of urinary symptoms was higher in females than males, and individuals with more severe urinary symptoms were generally older. There was no significant difference in terms of hospitalization history or the occurrence of severe urinary symptoms. Nocturia and frequency were the most prevalent symptoms among the patients.
Keywords : infection, subsequent lower urinary tract symptoms, COVID-19